Scope of the Study
The global coronavirus testing kits market is expected to grow at a significant rate during the forecast period, according to the AMA study. The rapid growth in number of COVID-19 suspect across the world and the opening of coronavirus test centers at different parts of countries across the world are expected to be major drivers of this market.
The market study is being classified, by Application (Infectious Diseases and Respiratory Diseases) and major geographies with country level break-up.
MyLab (India), Altona Diagnostics (Germany), BioMednomics (United States), Getein Biotech (China), Sensing Self Ltd (Singapore), AmonMed Biotechnology Co (China), Biomaxima (Poland), CTK Biotech (United States), Vivacheck Lab (China), Hangzhou Biotest Biotech (China), Wondfo (China), GenMark Diagnostics, Inc. (United States), XCR Diagnostics (United States), SensDx S.A. (Poland), Roche Molecular Systems, Inc. (United States), Thermo Fischer Scientific Inc. (United States), Hologic Inc (United States), LabCorp (United States) and Quest Diagnostics Infectious Disease Inc. (United States) are some of the key players profiled in the study.
The vendors in this market are trying to increase their production after taking the approvals from government & authorities to commercialise the product for public use. For instance, in March 2020, Hologic Inc., announced that it has got approval from FDA for its Panther Fusion SARS-CoV-2 testing kit product. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Coronavirus Testing Kits market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Coronavirus Testing Kits market by Type, Application and Region.
On the basis of geography, the market of Coronavirus Testing Kits has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Rapid Growth in Number of COVID-19 Suspects All Across the World
- The Opening of Coronavirus Test Centers at Different Parts of Countries Across the World
- Increasing Number of Investments for Research & Development of Coronavirus Testing Kits
- Raw Material Cost Fluctuations
- Gap in Supply Chain
- Huge Opportunities in North America and European Countries due to Most Number of Coronivirus Suspect Cases Across their Countires such as Italy, United States, Spain, France, and Germany
- Lack of Raw Material Supply
- Lack of Work Force for Manufacturing of Testing Kits
In March 2020, Roche Molecular Systems Inc. announced that it has got the FDA approval for its newly developed coronavirus testing kit cobas SARS-CoV-2.
Stringent Norms Regarding Clearing the Validation Requirement of Testing Kits
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase